Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.

Bibliographic Details
Main Authors:	Norton, A, Fisher, C, Liu, H, Wen, Q, Mundschau, G, Fuster, J, Hasle, H, Zeller, B, Webb, D, O'Marcaigh, A, Sorrell, A, Hilden, J, Gamis, A, Crispino, J, Vyas, P
Format:	Journal article
Language:	English
Published:	2007

Similar Items

JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia
by: Vyas, P, et al.
Published: (2008)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
by: Alford, K, et al.
Published: (2011)

Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome
by: Tunstall, O, et al.
Published: (2018)

Modification of the histone landscape with JAK inhibition in myeloproliferative neoplasms
by: Greenfield, G, et al.
Published: (2020)

Potential role of JAK-STAT signaling pathway in the neurogenic-to-gliogenic shift in down syndrome brain
by: Lee, Han Chung, et al.
Published: (2016)

The role of JAK-STAT signalling in the developing brain of Ts1Cje mouse model for Down syndrome
by: Lee, Han Chung, et al.
Published: (2015)

Frequent cases of RAS-mutated down syndrome acute lymphoblastic leukaemia lack JAK2 mutations
by: Nikolaev, Sergey I., et al.
Published: (2014)

Molecular insights into Down syndrome-associated leukemia.
by: Vyas, P, et al.
Published: (2007)

REST targets JAK–STAT and HIF-1 signaling pathways in human Down syndrome brain and neural cells
by: Huang, Tan, et al.
Published: (2023)

Gene aberrations and methylation analysis of JAK/stat and toll-like receptor downstream signalling in BCR-ABL-negative myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms overlap syndromes
by: Cai, Chia Yuh
Published: (2021)

Natural history of GATA-1 mutations in Down syndrome.
by: Ahmed, M, et al.
Published: (2003)

Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.
by: Gurbuxani, S, et al.
Published: (2004)

Natural history of GATA1 mutations in Down syndrome.
by: Ahmed, M, et al.
Published: (2004)

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
by: Hasle, H, et al.
Published: (2008)

Gene and protein expression profiles of JAK-STAT signalling pathway in the developing brain of the Ts1Cje down syndrome mouse model
by: Lee, Han Chung, et al.
Published: (2019)

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.
by: Beer, P, et al.
Published: (2008)

Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
by: Roy, A, et al.
Published: (2009)

JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition
by: McKenney, Anna Sophia, et al.
Published: (2018)

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
by: Heald, B, et al.
Published: (2007)

Musings of Jak /
by: 433224 Abdul Razak Rahman

Haematology of Down syndrome.
by: Webb, D, et al.
Published: (2007)

SLEEP DISRUPTION IN DOWNS-SYNDROME
by: Stradling, J
Published: (1988)

Down syndrome preleukemia and leukemia.
by: Maloney, K, et al.
Published: (2014)

Trilineage Perturbation of Hematopoiesis In Neonates with Down Syndrome
by: Norton, A, et al.
Published: (2010)

Trilineage Perturbation of Hematopoiesis In Neonates with Down Syndrome
by: Norton, A, et al.
Published: (2010)

Trilineage Perturbation of Hematopoiesis In Neonates with Down Syndrome
by: Norton, A, et al.
Published: (2010)

Acute megakaryoblastic leukaemia in Down syndrome and non-Down syndrome patients - molecular signature of a disease - subtypes with distinct treatment outcomes
by: Vyas, P, et al.
Published: (2007)

Prenatal screening of down syndrome.
by: Rosli, Rozita, et al.
Published: (2006)

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations.
by: Bench, A, et al.
Published: (2013)

Resources, Down's syndrome, and cardiac surgery.
by: Savulescu, J
Published: (2001)

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations
by: Bench, A, et al.
Published: (2013)

Speech and language intervention in down syndrome /
by: Rondal, Jean A (Jean Adolphe), et al.
Published: (2003)

Perceptual-motor behavior in down syndrome /
by: Weeks, Daniel J., 1956-
Published: (2000)

Acute leukemias in children with Down syndrome.
by: Zwaan, C, et al.
Published: (2010)

Acute leukemias in children with Down syndrome.
by: Zwaan, M, et al.
Published: (2008)

JAK 343 Kimia Koordinatan
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (1991)

JAK 231 - Kimia Takorganik
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (1992)

JAK 001 - Kimia I
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (1992)

JAK 002 - Kimia II
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (1992)

JAK 343 - Kimia Koordinatan
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (1992)